{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:32:11Z","timestamp":1759991531465},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2889,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1469-0691.2006.01617.x","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T13:59:38Z","timestamp":1162475978000},"page":"33-39","source":"Crossref","is-referenced-by-count":39,"title":["The contribution of pharmacokinetic\u2013pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis"],"prefix":"10.1016","volume":"13","author":[{"given":"D.S.","family":"Burgess","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"J.S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Fiebelkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01617.x_bib1","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00006454-199611000-00009","article-title":"Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience","volume":"15","author":"Kirsch","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-3476(81)80250-8","article-title":"Complications and sequelae of meningococcal infections in children","volume":"99","author":"Edwards","year":"1981","journal-title":"J Pediatr"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib5","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra021771","article-title":"How contagious are common respiratory tract infections?","volume":"348","author":"Musher","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib6","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JCM.43.7.3162-3171.2005","article-title":"Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents","volume":"43","author":"Jorgensen","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib7","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical Laboratory Standards Institute","year":"2005"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/158.1.200","article-title":"Evidence for a slow elimination phase for penicillin G","volume":"158","author":"Ebert","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000238765","article-title":"Pharmacokinetics of sulbactam\/ampicillin in humans after intravenous and intramuscular injection","volume":"36","author":"Ripa","year":"1990","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/AAC.23.3.429","article-title":"Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam","volume":"23","author":"Kemmerich","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jac\/dkg003","article-title":"Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers","volume":"50","author":"Chiu","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.40.1.105","article-title":"Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem\u2013cilastatin","volume":"40","author":"Dreetz","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01062543","article-title":"Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function","volume":"10","author":"Burke","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000238134","article-title":"Pharmacokinetics of tetracycline in nutritional edema","volume":"28","author":"Raghuram","year":"1982","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.8.5.532","article-title":"Pharmacokinetics of minocycline in renal failure","volume":"8","author":"Welling","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01062333","article-title":"Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing","volume":"10","author":"Oie","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/AAC.37.3.448","article-title":"Multiple\u2010dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers","volume":"37","author":"Stevens","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib18","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.41.12.2670","article-title":"Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide","volume":"41","author":"Peloquin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1128\/AAC.36.5.993","article-title":"Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses","volume":"36","author":"Lettieri","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/AAC.33.4.434","article-title":"Effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline","volume":"33","author":"Nguyen","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib21","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.41.10.2256","article-title":"Pharmacokinetic profile of levofloxacin following once\u2010daily 500\u2010milligram oral or intravenous doses","volume":"41","author":"Chien","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib22","series-title":"The Sanford guide to antimicrobial therapy","author":"Gilbert","year":"2002"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70096-9","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in meningitis","volume":"13","author":"Andes","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/514622","article-title":"The pharmacodynamics of beta\u2010lactams","volume":"27","author":"Turnidge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib26","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1086\/344653","article-title":"Prevention of resistance: a goal for dose selection for antimicrobial agents","volume":"36","author":"Drusano","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/jac\/dkg452","article-title":"Chloramphenicol\u2010resistant Neisseria meningitidis containing catP isolated in Australia","volume":"52","author":"Shultz","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/516994","article-title":"Meningococcal meningitis during penicillin therapy for meningococcemia","volume":"25","author":"Casado\u2010Flores","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/infdis\/170.2.453","article-title":"Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina","volume":"170","author":"Woods","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0140-6736(90)90852-V","article-title":"Treatment failure in meningococcal meningitis","volume":"335","author":"Turner","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0950268800067960","article-title":"Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations","volume":"99","author":"Saez\u2010Nieto","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199809243391302","article-title":"High\u2010level chloramphenicol resistance in Neisseria meningitidis","volume":"339","author":"Galimand","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00006454-198705000-00003","article-title":"Neisseria meningitidis strains with decreased susceptibility to penicillin","volume":"6","author":"Van Esso","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib35","first-page":"152","article-title":"Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01617.x_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1592\/phco.2005.25.7.935","article-title":"Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem","volume":"25","author":"Kuti","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14615536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14615536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T04:30:51Z","timestamp":1555907451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14615536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1198743X14615536"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01617.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}